Pain News and Research

Latest Pain News and Research

Omeros fourth quarter net loss increases to $7.2 million

Omeros fourth quarter net loss increases to $7.2 million

Research links frequent prescribing to opioid-related deaths

Research links frequent prescribing to opioid-related deaths

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

eToims launches new program with leading football franchise to improve athletic therapy

eToims launches new program with leading football franchise to improve athletic therapy

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

USPTO grants second patent to Angiochem's EPiC drugs

USPTO grants second patent to Angiochem's EPiC drugs

State roundup: Medicaid cuts cause unusual bedfellows

State roundup: Medicaid cuts cause unusual bedfellows

Surgeons use stem cell technology for bone grafts to treat foot, ankle conditions

Surgeons use stem cell technology for bone grafts to treat foot, ankle conditions

Hospice and Palliative care

Hospice and Palliative care

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

Alzheimer's vaccine - First evidence for efficacy

Alzheimer's vaccine - First evidence for efficacy

New drug for Lupus approved

New drug for Lupus approved

Updated NCCN Guidelines for Breast Cancer outline expanded treatment options

Updated NCCN Guidelines for Breast Cancer outline expanded treatment options

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex fourth quarter net loss increases to $7.0 million

Personal usage and patient recommendations for dietary supplements are quite common across specialties

Personal usage and patient recommendations for dietary supplements are quite common across specialties

Organ removal surgery through body's orifices, without any visible incisions

Organ removal surgery through body's orifices, without any visible incisions

Regence Foundation offers eight grants to hospitals for palliative care programs

Regence Foundation offers eight grants to hospitals for palliative care programs

SAMHSA study finds 51.5% drug-related hospital visits by older patients

SAMHSA study finds 51.5% drug-related hospital visits by older patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.